Exelixis | Marktkapitalisierung



Market Capitalization Veränderung Datum
Acadia Pharmaceuticals USD 3.61B 840M 2025-06
Agios Pharmaceuticals USD 1.93B 234M 2025-06
Amgen USD 150.13B 17.37B 2025-06
AstraZeneca GBP 215.51B 41B 2025-06
Bayer EUR 25.09B 3.38B 2025-06
BioMarin Pharmaceutical USD 10.54B 3.01B 2025-06
Bristol-Myers Squibb USD 94.2B 29.9B 2025-06
Cytokinetics USD 3.95B 846M 2025-06
Eli Lilly USD 738.79B 2.87B 2025-06
Genmab DKK 80.88B 7.82B 2025-06
Glaxosmithkline USD 82.21B 2.63B 2025-09
Incyte USD 13.18B 1.46B 2025-06
Ionis Pharmaceuticals USD 6.29B 1.49B 2025-06
MacroGenics USD 111M 34M 2025-09
Merck USD 198.77B 27.1B 2025-06
Moderna USD 10.67B 290M 2025-06
Neurocrine Biosciences USD 12.44B 1.5B 2025-06
Novartis CHF 256.18B 64.49B 2025-06
Pfizer USD 137.53B 6.19B 2025-06
Sanofi USD 125.19B 7.59B 2025-09
Takeda JPY 7.04T 19.15B 2025-06
Ultragenyx Pharmaceutical USD 3.44B 38M 2025-06
Xencor USD 559M 191M 2025-06


Exelixis Marktkapitalisierung - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Sep 2025.